A carregar...
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Optimal management of patients with relapsed/refractory chronic lymphocytic leukemia (CLL) is dictated by patient characteristics, prior therapy, and response to prior therapy. We report the final analysis of combined fludarabine, cyclophosphamide, and rituximab (FCR) for previously treated patients...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Hematology
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4123386/ https://ncbi.nlm.nih.gov/pubmed/21245487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-08-304683 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|